2RJ-13442-25044
4 vaccinations
1 coded response
42 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 601 / IL
- Registered
- 2021-06-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
B2Z-24920-81899
Child or adolescent in my care · Female · 2022-06-21
KGD-23110-08251
Child or adolescent in my care · Female · 2022-06-30
Timeline
-
2021-06-07
Registered in v-safe
-
2021-06-07
Dose 1 — Moderna
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-11
- 2021-06-12
- 2021-06-13
- 2021-06-14
- 2021-06-23
- 2021-06-28
-
2021-07-05
Dose 2 — Moderna
- 2021-07-05
-
2021-07-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-07-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-07-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-07-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-19
- 2021-07-26
- 2021-08-02
- 2021-08-09
- 2021-08-16
- 2021-10-04
- 2022-01-03
-
2022-02-05
Dose 3 — Moderna
- 2022-02-05
-
2022-02-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Chills, Headache, Muscle or body achesAdult check-in
- 2022-02-08
- 2022-02-09
- 2022-02-10
- 2022-02-11
- 2022-02-12
- 2022-02-19
- 2022-02-26
- 2022-03-07
- 2022-03-12
- 2022-03-19
- 2022-05-07
- 2022-08-06
-
2022-11-07
Dose 4 — Pfizer-BioNTech
-
2023-02-06
Survey response — 3 months, dose 4MedDRA: Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-02-06
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-02-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-07 | Moderna | |
| 2 | 2021-07-05 | Moderna | No |
| 3 | 2022-02-05 | Moderna | No |
| 4 | 2022-11-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-02-06 | Successful 2023-02-07 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release